Table of Contents
ISRN Cardiology
Volume 2011 (2011), Article ID 364728, 7 pages
http://dx.doi.org/10.5402/2011/364728
Research Article

Can We Exclude the Diagnosis of Non-ST Segment Myocardial Infarction on the Basis of a Single Troponin I and a Symptom Duration ≥8 Hours?

Department of Emergency Medicine, Alameda County Medical Center, Highland Hospital, Oakland, CA 94602-1018, USA

Received 13 February 2011; Accepted 17 March 2011

Academic Editor: A. D. Szekely

Copyright © 2011 Jeremy S. Lynn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Jaffe, J. Ravkilde, R. Roberts et al., “It's time for a change to a troponin standard,” Circulation, vol. 102, no. 11, pp. 1216–1220, 2000. View at Google Scholar · View at Scopus
  2. J. S. Alpert, E. Antman, F. Apple et al., “Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction,” European Heart Journal, vol. 21, no. 18, pp. 1502–1513, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. F. M. Fesmire, W. W. Decker, D. B. Diercks et al., “Clinical policy: critical issues in the evaluation and management of adult patients with non-ST-segment elevation acute coronary syndromes,” Annals of Emergency Medicine, vol. 48, no. 3, pp. 270–301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. H. B. Wu, F. S. Apple, W. B. Gibler, R. L. Jesse, M. M. Warshaw, and R. Valdes, “National academy of clinical biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases,” Clinical Chemistry, vol. 45, no. 7, pp. 1104–1121, 1999. View at Google Scholar · View at Scopus
  5. F. S. Apple, A. J. Maturen, R. E. Mullins et al., “Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction,” Clinical Chemistry, vol. 45, no. 2, pp. 206–212, 1999. View at Google Scholar · View at Scopus
  6. K. Richell-Herren and S. Maurice, “Troponin T to rule out myocardial damage in chest pain,” Journal of Accident and Emergency Medicine, vol. 17, no. 3, pp. 213–214, 2000. View at Google Scholar · View at Scopus
  7. F. S. Apple, A. H. B. Wu, and A. S. Jaffe, “European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials,” American Heart Journal, vol. 144, no. 6, pp. 981–986, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Tunstall-Pedoe, K. Kuulasmaa, P. Amouyel, D. Arveiler, A. M. Rajakangas -, and A. Pajak, “Myocardial infarction and coronary deaths in the World Health Organization MONICA project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents,” Circulation, vol. 90, no. 1, pp. 583–612, 1994. View at Google Scholar · View at Scopus
  9. C. W. Hamm, B. U. Goldmann, C. Heeschen, G. Kreymann, J. Berger, and T. Meinertz, “Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I,” New England Journal of Medicine, vol. 337, no. 23, pp. 1648–1653, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Limkakeng, W. B. Gibler, C. Pollack et al., “Combination of goldman risk and initial cardiac troponin I for emergency department chest pain patient risk stratification,” Academic Emergency Medicine, vol. 8, no. 7, pp. 696–702, 2001. View at Google Scholar · View at Scopus
  11. J. McCord, R. M. Nowak, P. A. McCullough et al., “Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I,” Circulation, vol. 104, no. 13, pp. 1483–1488, 2001. View at Google Scholar · View at Scopus
  12. S. M. Ng, P. Krishnaswamy, R. Morissey, P. Clopton, R. Fitzgerald, and A. S. Maisel, “Ninety-minute accelerated critical pathway for chest pain evaluation,” American Journal of Cardiology, vol. 88, no. 6, pp. 611–617, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. S. W. Zarich, A. U. Qamar, M. J. Werdmann, L. S. Lizak, C. A. McPherson, and L. H. Bernstein, “Value of a single troponin T at the time of presentation as compared to serial CK-MB determinations in patients with suspected myocardial ischemia,” Clinica Chimica Acta, vol. 326, no. 1-2, pp. 185–192, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. W. Smith, C. D. Tibbles, F. S. Apple, and M. Zimmerman, “Outcome of low-risk patients discharged home after a normal cardiac troponin I,” Journal of Emergency Medicine, vol. 26, no. 4, pp. 401–406, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Thygesen, J. S. Alpert, and H. D. White, “Universal definition of myocardial infarction,” Circulation, vol. 116, no. 22, pp. 2634–2653, 2007. View at Publisher · View at Google Scholar
  16. G. L. Pierpont and E. O. McFalls, “Interpreting troponin elevations: do we need multiple diagnoses?” European Heart Journal, vol. 30, no. 2, pp. 135–138, 2009. View at Publisher · View at Google Scholar · View at Scopus